Beacon NewsFlashes – February 6, 2012 - The Myeloma Beacon
Beacon NewsFlashes – February 6, 2012The Myeloma BeaconViracept Demonstrates Anti-Myeloma Activity – Results of a recent preclinical trial show that Viracept (nelfinavir), alone or in combination with other common myeloma drugs, prevents myeloma cell growth and causes cell death.
Antiretrovirals Raise Birth Defect Risk - Medical News Today
Antiretrovirals Raise Birth Defect RiskMedical News TodayThe findings of the new study identified 26 incidents of cleft lip and palate related to seven antiviral drugs, namely efavirenz, lamivudine, nelfinavir, and the combination of abacavir/sulfate/laminudine/zidovudine.
Study Looks at Possible HIV Drugs-Birth Defect Link - Health.com
MD NewsStudy Looks at Possible HIV Drugs-Birth Defect LinkHealth.
ESOMEPRAZOLE 20MG RANBAXY CPR 7 - Medisite
MedisiteESOMEPRAZOLE 20MG RANBAXY CPR 7MedisiteL'ésoméprazole ne doit pas être utilisé de façon concomitante avec le nelfinavir (voir rubrique Interactions avec d'autres médicaments et autres formes d'interactions).